Wideopenwest Inc is a telecommunications provider that specializes in delivering high-speed internet, digital cable television, and phone services primarily to residential and business customers
The company focuses on enhancing connectivity and providing quality entertainment options through its advanced fiber-optic networks, ensuring reliable service in the regions it serves. By leveraging innovative technologies and customer-centric solutions, Wideopenwest aims to meet the growing demands for broadband access and enhance the overall user experience in the digital age.
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the wireless, cable and satellite industry, including Verizon (NYSEVZ) and its peers.
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the wireless, cable and satellite industry, including Cable One (NYSECABO) and its peers.
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the wireless, cable and satellite industry, including WideOpenWest (NYSEWOW) and its peers.
Broadband and telecommunications services provider WideOpenWest (NYSEWOW) met Wall Street’s revenue expectations in Q3 CY2024, but sales fell 8.7% year on year to $158 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $631 million at the midpoint. Its GAAP loss of $0.27 per share was 162% below analysts’ consensus estimates.
Broadband and telecommunications services provider WideOpenWest (NYSEWOW) will be announcing earnings results tomorrow after market hours. Here’s what to expect.
WideOpenWest, Inc (NYSEWOW) reported 4Q revenue decline of 6% YoY to $168.8M, missing consensus of $170.6M. EPS loss of $(0.54) missed consensus of $(0.01). Stock price slipped. 504,100 total subscribers as of 12/31/23. Guidance expects 1Q revenue of $159M-$162M.
Shares of Clover Health Investments, Corp. (NASDAQCLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQSGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
